Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07124546
NA

Acceptance and Commitment Therapy for the Improvement of Cancer Distress in Patients With Incurable Cancers, ACT-C Trial

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

This clinical trial studies whether Acceptance and Commitment Therapy can be used to help improve cancer distress for patients with hepatobiliary or breast cancers for which no treatment is currently available (incurable). Patients with hepatobiliary cancer (HBC) and breast cancer often experience high levels of distress and reductions in quality of life. Acceptance and Commitment Therapy for incurable cancers (ACT-C) is a behavioral intervention tailored to patients with incurable HBC and breast cancer. It helps patients cope with difficult thoughts and emotions while staying connected to what matters most in life, which may be an effective way to improve cancer distress.

Official title: Development of Acceptance and Commitment Therapy for Cancer Distress Among Rural and Urban Patients With Incurable Cancers (ACT-C)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-05-28

Completion Date

2027-05-30

Last Updated

2026-08-04

Healthy Volunteers

No

Interventions

BEHAVIORAL

Acceptance and Commitment Therapy

Attend ACT-C telehealth group sessions

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Telemedicine

Attend ACT-C telehealth group sessions

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States